Navigation Links
Zimmer Announces New Compliance Model
Date:4/17/2008

Company Initiates Fundamental Changes to Create a Sustainable Model for

Growth

WARSAW, Ind., April 17 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) today announced comprehensive changes in its corporate compliance model aimed at establishing an enhanced standard for ethical business practices that will support the development and marketing of products and services that address unmet clinical needs and better serve the healthcare markets of the future.

The refined compliance model is designed to aggressively reduce potential or perceived conflicts of interest inherent in consulting relationships between the industry and healthcare professionals-while preserving the best of the collaboration that drives innovation in medical devices and services. The model includes fundamental changes in the areas of product development, marketing, surgeon training, educational and charitable funding, and transparency.

"Collaboration with physicians will always be critical to advancing medical technology that improves patients' lives. But the historical model for collaboration requires change to continue inspiring the confidence and trust of our stakeholders," said David Dvorak, Zimmer Holdings President and Chief Executive Officer. "The new model we have recently developed at Zimmer implements principles and systems that we believe will drive greater transparency, value to the healthcare system and even more efficient and effective product development cycles. We consider these to be emerging best practices that are necessary to ensure a vibrant future for the medical device industry and for the patients our industry serves."

This model builds upon Zimmer's existing Corpor
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Zimmer Announces Actions Affecting its Ohio-based Orthopaedic Surgical Products Operation
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results
3. Zimmer Holdings to Present at Upcoming Investor Conferences
4. Zimmer to Expand Manufacturing Network
5. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
6. Zimmer Reports Fourth Quarter and 2007 Financial Results
7. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. Zimmer Holdings to Present at JPMorgan Healthcare Conference
10. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
11. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sentine...anceImaging(MRI)coilsandsoftwareandCalgaryScientif...ies,haveintroducedawebversionofAegis(TM)Breast4DAd...nterfaceisthefirsttrulyzero-footprintWebclientbase...ic,sPureWeb(TM)platformallowsforzero-footprintacce...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswir...,sCenterforDrugEvaluationandResearch,titled"ADiffi...ppearsintheNov.26,2009issueofTheNewEnglandJournalo...-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,Wo...cesstopainmedicationforthosewhoneeditandmanagingth...
(Date:11/25/2009)...,, BroadPoliticalEndorsements,Business,andPres...RNewswire-USNewswire/--Onceagain,theNationalBipola...amationendorsingtheir"Safe,tilStable"program,which...sureforbipolardisorder.Today,theNationalBipolarFou...lExpressPriorityMailfromtheLt.GovernorofLouisianaM...
(Date:11/25/2009)... A fortuitous discovery that grew out of a collab...d potentially offer hope to the nearly 10 million ...ase. , Also known as hardening of the arteri...on circulatory problem in which narrowed arteries ...onsidered a red flag for vascular disease, heart a...
(Date:11/25/2009)...tuximab, already used to fight rheumatoid arthriti...ds , , WEDNESDAY, Nov. 25 (HealthDay New...lymphoma and rheumatoid arthritis now also shows s...th type 1 diabetes. , The drug, rituximab (Ritu... own insulin, even though the disease had destroye...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...t it is all over between Kate Moss and Pete Dohert...ican model , it seems that the waifish beauty will...implant. The implant will be the fifth one... she understands that Doherty needs help and will ...
...ammed Haneef, the man from Bangalore in southern I...avy price for a small act of indiscretion, it look...his cousins, the key players in the failed Glasgow...ly to crash. First Australian authorities alm...
...that more than 90 per cent of women undergoing fer...f fertility drugs meant to stimulate their ovaries...ans that the drugs may not work properly, but also...however increased during IVF, by giving them drugs...
...ol of Public Health (HSPH) shows that patients who...ic quality measures have a lower chance of dying ... The researchers calculate that if the lowest p... surveyed hospitals from acute myocardial infarcti...
...ess' has been named the most vegan-friendly food c...d by the animal rights group for its cheese-free p...is one of the 20 organisations recognised by PETA ...London with a pizza oven and chef imported from It...
...started walking on two legs is something yet to be...sized that bipedalism evolved as a way of reducin... study to fully examine this theory among humans a...ll trials to analyze walking energetics and biomec...
Other Medicine News:Health News:Haneefs Visa Revoked by Australia 2Health News:Lower Mortality Rates in Hospitals With Good Quality Care 2
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...ov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML)...fReorganizationandDisclosureStatementtoday,Novembe...istrictofDelaware.AhearingtoconsiderapprovaloftheD...,2009,withthehearingontheconfirmationofthePlansche...panytopayallclaimsinfull.ThePlanisexpected,ifappro...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 1Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 2Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 3Greenway Medical Technologies Enhances Advisory and Consulting Partnership Strategies with Regional Extension Centers 61548 4Ultimat Vodka Joins Fight Against Hunger 61545 1Ultimat Vodka Joins Fight Against Hunger 61545 2Shopko Announces Launch of e Commerce Platform 61542 1Shopko Announces Launch of e Commerce Platform 61542 2
...HAYWARD, Calif., Aug. 6 Kosan Biosciences,Incorpo... Inc. has initiated,a Phase 1 clinical trial of mo...187, a selective and potent motilin receptor agoni...hageal reflux disease (GERD) and potentially,other...ical trial is,designed to test the safety, tolerab...
...SAN DIEGO, Aug. 7 Vical Incorporated (Nasdaq:,VIC...r ended June 30, 2007.,Revenues for the second qua...nues of $7.3 million for the second quarter of 200... $8.2 million, or $0.21 per share, compared,with a... the second quarter,of 2006. The increase in net l...
Other Medicine Technology:Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 2Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 3Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6
Jeweler Type Bipolar Insulated Forceps
Robb Tonsil Knife
Canfield Tonsil Knife
Converse Button End Bistoury
Medicine Products: